New hope for kids with Tough-to-Treat blood cancer
NCT ID NCT04915612
Summary
This study tested a new combination of three cancer drugs for children and young adults whose acute myeloid leukemia has returned or not responded to previous treatments. The main goal was to find the safest dose and understand the side effects of combining these medications. Researchers also wanted to see if this combination could help control the cancer and prepare patients for a possible bone marrow transplant.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RECURRENT ACUTE MYELOID LEUKEMIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
M D Anderson Cancer Center
Houston, Texas, 77030, United States
Conditions
Explore the condition pages connected to this study.